Based on TCGA dataset and the optimal cutoff value, the survival rate was significantly better in breast cancer patients (n = 726) with high expression of CLIP4 than in those with low expression (n = 349) (p = 0.020, <0.05) (https://www.proteinatlas.org/) (Figure 3D). This evidence concerns the gene CLIP4 and breast carcinoma.